TOP STORIES
respiratory
Bronchiectasis

STOP-COVID19 trial to test novel bronchiectasis treatment


Respiratory researchers in the UK are launching a trial to test a novel treatment for inflammatory lung conditions in hospitalised Covid-19 patients. Brensocatib, a reversible inhibitor of dipeptidyl peptidase 1 (DPP1) currently being developed by biopharmaceutical company Insmed, will be tested...

Respiratory researchers in the UK are launching a trial to test a novel treatment for inflammatory lung conditions in hospitalised...

Read more